Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276363 · ClinicalTrials.gov registry record · NA
Families, Children and Teachers Thriving Together
A NA study of Emotional Stress and Social Anxiety, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 491
- Enrollment target
- 1
- Study location
NCT04276363: Active NA study of Emotional Stress and Social Anxiety, sponsored by NYU Langone Health.
NCT04276363 is a NA study of Emotional Stress and Social Anxiety that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 491 participants, above the 370-participant average among 3 other Emotional Stress trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04276363, a NA study of Emotional Stress and Social Anxiety, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 491 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU Langone Health is implementing services to strengthen family engagement and support parents and teachers in creating safe, nurturing and predictable environments for young children. All parents of Pre-K students in the 81 district schools will be invited for them and their Pre-K children to participate in the study, which includes 2 school-based assessments in Pre-K over a 10-month period and 1 school-based assessment at the end of Kindergarten, and teacher ratings of children in Pre-K and Kindergarten. Additionally, parents will be invited to consent to the use of their children's NYC DOE administrative records from Pre-K through grade 5 for the purposes of this study. Parents will also be invited to participate by completing surveys with NYU study staff. Parents will be consented to complete two surveys when their child is in Pre-K. Parents may be randomly selected to complete a third survey when their child is in Kindergarten or to participate in a focus group with other parents.
Primary Outcome
Parents report on the Anger subscale from the NIH Toolbox Emotion Battery. This measure was designed for children ages 3 - 7. The Anger subscale includes 9 items which measure attitudes of hostility and cynicism often associated with experiences of frustration impeding goal-directed behavior. Parents are asked to respond to items on a three-point scale ranging from "Never True" to "Often True". The NIH Toolbox uses a T-score metric where a score of 50 is the mean and 10 is the standard deviation
Conditions Studied
Interventions
- BEHAVIORAL Thrive Professional Learning plus ParentCorps
- BEHAVIORAL Thrive Professional Learning only
- BEHAVIORAL Inspire Professional Learning
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT04276363 still lists
NCT04276363 is an interventional study that assigns participants to a tested intervention. The registered 491 participants enrollment target is mid-sized for trials with a published cap, above the 370-participant average among 3 other Emotional Stress trials with a reported enrollment target (33% higher).
The record links to 2 conditions, with Emotional Stress appearing as the primary indexed condition, and to 3 interventions - of which Thrive Professional Learning plus ParentCorps is the first listed.
NCT04276363 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04276363 about?
NCT04276363 is a clinical study titled "Families, Children and Teachers Thriving Together". The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development ...
What is the current status of trial NCT04276363?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 491 participants. The study started on 2019-11-14. Estimated completion is 2026-08-31.
What conditions does trial NCT04276363 study?
This clinical trial studies the following conditions: Emotional Stress, Social Anxiety.
What interventions are being tested in trial NCT04276363?
The interventions under investigation include: Thrive Professional Learning plus ParentCorps (BEHAVIORAL), Thrive Professional Learning only (BEHAVIORAL), Inspire Professional Learning (BEHAVIORAL).
Who is sponsoring clinical trial NCT04276363?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04276363 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emotional Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03418961 · 491 participants · Phase 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI